155 related articles for article (PubMed ID: 38701029)
1. Financial impact of integrated specialty pharmacy efforts to avoid oral anticancer medication waste.
Looney B; Crumb J; White S; Jones G; Moore RP; Choi L; Zuckerman AD; Whelchel K
J Manag Care Spec Pharm; 2024 May; 30(5):465-474. PubMed ID: 38701029
[TBL] [Abstract][Full Text] [Related]
2. Advancing Patient Care Through Specialty Pharmacy Services in an Academic Health System.
Bagwell A; Kelley T; Carver A; Lee JB; Newman B
J Manag Care Spec Pharm; 2017 Aug; 23(8):815-820. PubMed ID: 28737983
[TBL] [Abstract][Full Text] [Related]
3. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
4. Effect of clinical pharmacist interventions on cost in an integrated health system specialty pharmacy.
Lankford C; Dura J; Tran A; Lam SW; Naelitz B; Willner M; Geyer K
J Manag Care Spec Pharm; 2021 Mar; 27(3):379-384. PubMed ID: 33645240
[No Abstract] [Full Text] [Related]
5. Cost avoidance from health system specialty pharmacist interventions in patients with multiple sclerosis.
Georgieva D; Markley B; DeClercq J; Choi L; Zuckerman AD
J Manag Care Spec Pharm; 2024 Apr; 30(4):336-344. PubMed ID: 38555624
[TBL] [Abstract][Full Text] [Related]
6. Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System.
de Oliveira DR; Brummel AR; Miller DB
J Manag Care Spec Pharm; 2020 Sep; 26(9):1057-1066. PubMed ID: 32857651
[TBL] [Abstract][Full Text] [Related]
7. Medication therapy management: 10 years of experience in a large integrated health care system.
Ramalho de Oliveira D; Brummel AR; Miller DB
J Manag Care Pharm; 2010 Apr; 16(3):185-95. PubMed ID: 20331323
[TBL] [Abstract][Full Text] [Related]
8. Financial impact from in-office dispensing of oral chemotherapy.
Howard A; Kerr J; McLain M; Modlin J
J Oncol Pharm Pract; 2019 Oct; 25(7):1570-1575. PubMed ID: 30249154
[TBL] [Abstract][Full Text] [Related]
9. Estimated Cost and Savings in a Patient Management Program for Oral Oncology Medications: Impact of a Split-Fill Component.
Staskon FC; Kirkham HS; Pfeifer A; Miller RT
J Oncol Pract; 2019 Oct; 15(10):e856-e862. PubMed ID: 31465250
[TBL] [Abstract][Full Text] [Related]
10. The Effect of an Integrated Health System Specialty Pharmacy on HIV Antiretroviral Therapy Adherence, Viral Suppression, and CD4 Count in an Outpatient Infectious Disease Clinic.
Barnes E; Zhao J; Giumenta A; Johnson M
J Manag Care Spec Pharm; 2020 Feb; 26(2):95-102. PubMed ID: 32011966
[TBL] [Abstract][Full Text] [Related]
11. Utilization, Cost, and Pricing Scheme of Compounded Medications for Public Health System Patients: The California Workers' Compensation System, 2011-2013.
Lin TK; Shoair OA; Tran D; Wilson L
J Manag Care Spec Pharm; 2019 Jul; 25(7):743-751. PubMed ID: 31232208
[TBL] [Abstract][Full Text] [Related]
12. Managing specialty medication services through a specialty pharmacy program: the case of oral renal transplant immunosuppressant medications.
Tschida S; Aslam S; Khan TT; Sahli B; Shrank WH; Lal LS
J Manag Care Pharm; 2013; 19(1):26-41. PubMed ID: 23383705
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
[TBL] [Abstract][Full Text] [Related]
14. The Role of Patient Financial Assistance Programs in Reducing Costs for Cancer Patients.
Zullig LL; Wolf S; Vlastelica L; Shankaran V; Zafar SY
J Manag Care Spec Pharm; 2017 Apr; 23(4):407-411. PubMed ID: 28345445
[TBL] [Abstract][Full Text] [Related]
15. Expanding pharmacy practice through the use of pharmacy technicians as process navigators to facilitate patient access of oral anticancer agents.
Lau G; Alwan L; Chi M; Lentz M; Hone K; Segal E
J Am Pharm Assoc (2003); 2019; 59(4):586-592. PubMed ID: 31036528
[TBL] [Abstract][Full Text] [Related]
16. Avoidance of drug interactions with hepatitis C treatment: Evaluation of pharmacist interventions in the specialty setting.
Huntley M; McCall K; Stickney K; Gelinas A; Levesque E
J Am Pharm Assoc (2003); 2022; 62(5):1671-1674. PubMed ID: 35589531
[TBL] [Abstract][Full Text] [Related]
17. Effect of a Smart Pill Bottle and Pharmacist Intervention on Medication Adherence in Patients with Multiple Myeloma New to Lenalidomide Therapy.
Mauro J; Mathews KB; Sredzinski ES
J Manag Care Spec Pharm; 2019 Nov; 25(11):1244-1254. PubMed ID: 31663462
[TBL] [Abstract][Full Text] [Related]
18. Pharmacist-managed short-acting beta agonist refill service in a general pediatric clinic.
Gildon BL; John B; Condren M; Keast S; Maglunog R; Johnson JL; Robertson C
J Am Pharm Assoc (2003); 2018; 58(3):296-302. PubMed ID: 29402662
[TBL] [Abstract][Full Text] [Related]
19. Targeting Financial Toxicity in Oncology Specialty Pharmacy at a Large Tertiary Academic Medical Center.
Farano JL; Kandah HM
J Manag Care Spec Pharm; 2019 Jul; 25(7):765-769. PubMed ID: 31232209
[TBL] [Abstract][Full Text] [Related]
20. Comparison of time to treatment initiation of specialty medications between an integrated health system specialty pharmacy and external specialty pharmacies.
Russell M; McCoy H; Platt T; Zeltner M; Rhudy C
J Manag Care Spec Pharm; 2024 Apr; 30(4):352-362. PubMed ID: 38555622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
